Sylvain de Lucia1, Bernard Hirschel
1Division des Maladies Infectieuses, Hôpital Cantonal de Genève. Sylvain.deLucia@hcuge.ch
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Post-exposure prophylaxis (PEP) for HIV is increasingly used, but risks and costs often outweigh benefits for most exposures. Careful risk-benefit assessment is crucial to avoid overprescription and manage patient fears.
Area of Science:
Context:
Purpose:
Summary:
Impact: